Is chronic plaque psoriasis triggered by microbiota in the skin?

被引:109
作者
Fry, L. [1 ]
Baker, B. S.
Powles, A. V. [1 ]
Fahlen, A. [2 ]
Engstrand, L. [2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden
关键词
INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE-RECEPTORS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; INNATE IMMUNITY; ANTIMICROBIAL PEPTIDES; ETIOLOGIC FACTOR; CHROMOSOME; 1Q21; CUTTING EDGE; PSORS4; LOCUS;
D O I
10.1111/bjd.12322
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
There is a known association between psoriasis and Crohn disease (CD). Patients with CD are five times more likely to develop psoriasis, and, conversely, patients with psoriasis are more likely to develop CD. Many gastroenterologists now accept that CD results from a breakdown of immune tolerance to the microbiota of the intestine in genetically susceptible individuals. The microbiota of the skin have recently been investigated in psoriasis. Firmicutes was the most common phylum, and Streptococcus the most common genus identified. Beta-haemolytic streptococci have been implicated in both guttate and chronic plaque psoriasis. Furthermore, the innate immune system has been shown to be activated in psoriasis, and many of the genes associated with the disease are concerned with the signalling pathways of the innate immune system, notably interleukin-23 and nuclear factor B. Patients with psoriasis also have an increased incidence of periodontitis, a disease thought to be due to an abnormal response to normal oral commensals. Based on the similarities between CD and psoriasis, we propose that psoriasis is due to a breakdown of immune tolerance to the microbiota of the skin. In support of this hypothesis we provide evidence for microbiota in the skin, activation of the innate immune system, and genetic abnormalities involving the innate immune system.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 61 条
[1]
[Anonymous], DIS SKIN
[2]
Peptidoglycan and peptidoglycan-specific ThI cells in psoriatic skin lesions [J].
Baker, B. S. ;
Laman, J. D. ;
Powles, A. ;
van der Fits, L. ;
Voerman, J. S. A. ;
Melief, M-J ;
Fry, L. .
JOURNAL OF PATHOLOGY, 2006, 209 (02) :174-181
[3]
Peptidoglycan: a major aetiological factor for psoriasis? [J].
Baker, Barbara S. ;
Powles, Anne ;
Fry, Lionel .
TRENDS IN IMMUNOLOGY, 2006, 27 (12) :545-551
[4]
Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis [J].
Baker, BS ;
Ovigne, JM ;
Powles, AV ;
Corcoran, S ;
Fry, L .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (04) :670-679
[5]
BJARNASON I, 1983, GASTROENTEROLOGY, V85, P318
[6]
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease [J].
Brand, S. .
GUT, 2009, 58 (08) :1152-1167
[7]
PSORIASIS IN AN UNSELECTED SERIES OF TWINS [J].
BRANDRUP, F ;
HAUGE, M ;
HENNINGSEN, K ;
ERIKSEN, B .
ARCHIVES OF DERMATOLOGY, 1978, 114 (06) :874-878
[8]
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors [J].
Brightbill, HD ;
Libraty, DH ;
Krutzik, SR ;
Yang, RB ;
Belisle, JT ;
Bleharski, JR ;
Maitland, M ;
Norgard, MV ;
Plevy, SE ;
Smale, ST ;
Brennan, PJ ;
Bloom, BR ;
Godowski, PJ ;
Modlin, RL .
SCIENCE, 1999, 285 (5428) :732-736
[9]
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21 [J].
Capon, F ;
Semprini, S ;
Chimenti, S ;
Fabrizi, G ;
Zambruno, G ;
Murgia, S ;
Carcassi, C ;
Fazio, M ;
Mingarelli, R ;
Dallapiccola, B ;
Novelli, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (05) :728-730
[10]
Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways [J].
Capon, Francesca ;
Burden, A. David ;
Trembath, Richard C. ;
Barker, Jonathan N. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (03) :915-922